#PortfolioNews | Memo Therapeutics partners with CSL to advance recombinant polyclonal IgG, validating its DROPZYLLA® platform. 🚀🧬
👉 buff.ly/uCOUhUh
#YsiosPortfolio
Hashtag
#YsiosPortfolio
Advertisement · 728 × 90
0
0
0
0
VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment
📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
3
0
0
0
#PortfolioNews I Our #portfolio company ONA Therapeutics strengthens leadership to accelerate first-in-class #ADCs targeting resistant #cancer cells & advancing toward #clinical development.
📢 Read more here https://buff.ly/4gK9vh3
#Oncology #Biotech #Pharma #YsiosPortfolio
2
0
0
0